FOX News: Business
FOXBusiness.com - Breaking news and video. Latest Current News: News, Investing, Technology, Personal Finance, Business Leaders, Travel, On Air, Small Business.
Updated: 13 min 46 sec ago
Image source: Intel.
Image source: BIGSTOCK.
The Institute for Supply Management’s gauge of factory activity in the Midwest region fell to 55.8 in July from 56.8 the month prior. Wall Street expected a larger decline to a reading of 54.0. Readings above 50 point to expansion, while those below indicate contraction
Over the past year and a half, Spirit Airlines (NASDAQ: SAVE) has been struggling with the steepest unit revenue declines in the airline industry.
Dow component Chevron reported a 2Q loss of $0.78 per share. Wall Street was expecting a profit of $0.32. Revenue for the company came in at $29.28 billion, topping the estimate for $28.54 billion
The U.S. economy grew far less than expected in the second quarter as inventories fell for the first time since 2011, but a surge in consumer spending pointed to underlying strength.
For many of us, our 20s are a time to experience somewhat of a financial wake-up call.
Exxon Mobil, the world's largest publicly traded oil producer, said on Friday its quarterly profit tumbled 59 percent due to the slump in crude prices.
Image source: Getty Images.
United Parcel Service reported a higher quarterly net profit on Friday as revenue grew across all its business units and the company benefited from cost-cutting measures.
Would you be able to handle an unexpected expense, such as your car breaking down? Image source: Getty Images.
The Converse Auckland Modern released this summer.
NextEra Energy agreed to buy Energy Future Holdings' stake in Oncor, in a deal that values the electricity transmissions business at $18.4 billion.
Xerox Corp. said Friday it had net income of $155 million, or 15 cents a share, in the second quarter, up from $12 million, or 1 cent a share, in the year-earlier period.
Merck & Co. reported Friday second-quarter earnings that rose to $1.21 billion, or 43 cents a share, from $687 million, or 24 cents a share, in the same period a year ago.
Merck & Co reported better-than-expected quarterly profit and revenue, helped by growing demand for its new cancer treatment, Keytruda.